Tellgen
Shanghai, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
Chinese diagnostics company building an integrated 'Diagnosis + Therapy' ecosystem with focus on autoimmune diseases.
Immunology
Technology Platform
Portfolio of advanced diagnostic solutions with focus on autoimmune diseases, though specific technology platforms are not detailed on accessible website content.
Opportunities
Growth in China's autoimmune disease diagnostics market and potential expansion into therapeutics through the CytoCares partnership and integrated ecosystem strategy.
Risk Factors
Execution risk in transitioning from diagnostics to therapeutics, competition in China's crowded diagnostics market, and dependency on strategic partnership success.
Competitive Landscape
Competes with numerous Chinese diagnostics companies and multinational IVD players; differentiation through integrated 'Diagnosis + Therapy' approach for autoimmune diseases.